Related Experiment Video
Updated: Sep 14, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Transformation From Oxyntic Gland Neoplasm Into Advanced Gastric Cancer via TP53 Mutation: A First Case Report
Akiko Komatsu1, Hirofumi Rokutan1, Naoko Arai2
1Department of Pathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
Abstract:
The molecular genetic mechanisms behind oxyntic gland neoplasm (OGN) progression are not well established. We present the first case suggesting that a TP53 mutation caused the transformation from OGN into advanced gastric cancer with nodal metastasis. An 80-year-old man presented with anemia and was found to have a gastric tumor measuring 35 × 30 mm. Histology revealed predominantly invasive tubular adenocarcinoma showing diffuse p53 positivity, with a minor chief cell-predominant OGN component. Targeted sequencing of the entire tumor revealed a pathogenic TP53 c.832C>A (p.Pro278Thr) mutation; no mutations were found in GNAS or KRAS. A double stain (p53/MUC5AC) provided immunohistochemical evidence of a shift from wild-type to mutant-type p53 expression, particularly in the foveolar epithelium within the intramucosal OGN component, suggesting the acquisition of a TP53 mutation during tumor progression. This case supports an unreported role for TP53 in the transformation of OGNs into aggressive carcinomas.
More Related Videos
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Related Concept Videos
Gastritis II: Pathophysiology
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...